DEEPX (CEO Lokwon, Kim), a frontrunner in AI chip technology, defines the critical technology for commercializing generative AI as the 'Federated Operation of LLM' and is advancing in its...

XNK Therapeutics AB ("XNK") today announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy event on February 14. XNK's presentation starts at...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor...

CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for...

Matson, Inc. (NYSE: MATX) announced today that Matt Cox, Chairman and Chief Executive Officer, and Joel Wine, Executive Vice President and Chief Financial Officer, will be attending the Stifel...